HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Study of Provider Computer Alerts Designed to Improve Delivery of HIV Care [NA]
A completed clinical trial evaluating provider computer alerts designed to improve HIV care delivery.
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised
This is a completed clinical trial update about using antiretroviral drugs to control acute or early HIV infection. It notes that a candidat…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Trial Embedded in an Electronic Personal Medical Health Records [NA]
Sponsored by the University of California, San Francisco, a clinical trial evaluating an electronic personal health record–embedded approach…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: HIV Prevention for African American Teens [Phase 3]
Phase 3 clinical trial update on HIV prevention for African American teens; the study has completed.
-
CLINICAL_TRIALS research · 2013-11-19Clinical Trial Update: Acute HIV Infection Observational Study
The Acute HIV Infection Observational Study sponsored by the National Institute of Allergy and Infectious Diseases has completed. The study …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: IMARA, Adapting SiHLE for Detained African American Adolescent Females [NA]
A completed clinical trial update for the IMARA program, adapting the SiHLE intervention for detained African American adolescent females to…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: HORIZONS HIV Intervention [NA]
Clinical trial update for an HIV intervention conducted by Emory University; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults [NA]
Completed clinical trial evaluating observed and self-administered drug regimens in adults with HIV infection; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Modified Directly Observed Antiretroviral Therapy [NA]
This document provides a clinical trial update for Modified Directly Observed Antiretroviral Therapy in HIV, sponsored by Moi University, wi…
-
CLINICAL_TRIALS trial_result · 2013-11-14Clinical Trial Update: Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated Patients [Phase 2]
Phase II study evaluating BILR 355 BS in HIV-1 infected, NNRTI-treated patients was terminated.
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children [Phase 1]
This Phase 1 pharmacokinetic study comparing twice-daily versus once-daily lamivudine (3TC) and abacavir (ABC) as part of combination ART in…
-
CLINICAL_TRIALS withdrawal · 2013-11-13Clinical Trial Update: Immune Response to Hepatitis C Virus
A clinical trial evaluating the immune response to hepatitis C virus sponsored by Emory University has been withdrawn from the registry.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects [Phase 2]
Phase 2 dose-ranging trial of GSK1349572 with 2 NRTIs in therapy-naive HIV-1–infected subjects has completed with results posted.
-
CLINICAL_TRIALS research · 2013-11-11Clinical Trial Update: A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir [Phase 4]
This Phase 4 pharmacokinetic study examines the pharmacokinetics of a triple protease inhibitor combination (indinavir, ritonavir, amprenavi…
-
FDA approval · 2013-11-08FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for EMTRIVA (emtricitabine) filed by Gilead Sciences, Inc.
-
FDA approval · 2013-11-08FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for EMTRIVA (emtricitabine) submitted by Gilead Sciences.
-
FDA approval · 2013-11-08FDA Approved: TRUVADA — Supplemental Application (Gilead Sciences, Inc)
FDA approved a supplemental application for TRUVADA (emtricitabine and tenofovir disoproxil fumarate) from Gilead Sciences, Inc. The action …
-
FDA approval · 2013-11-08FDA Approved: COMPLERA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for COMPLERA (emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate) from …
-
FDA approval · 2013-11-08FDA Approved: STRIBILD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for STRIBILD (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate) from G…
-
FDA approval · 2013-11-07FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for PREZISTA (darunavir) from Janssen Products LP.
-
FDA approval · 2013-11-07FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for PREZISTA (darunavir) submitted by Janssen Products LP, representing a supplemental approval to t…
-
FDA approval · 2013-11-07FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie Inc.
-
FDA approval · 2013-11-07FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
FDA approved AbbVie's supplemental application for NORVIR (ritonavir).
-
FDA approval · 2013-11-07FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie Inc.
-
CLINICAL_TRIALS trial_result · 2013-11-07Clinical Trial Update: A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally [Phase 1]
Phase 1 study comparing three rectal formulations of Tenofovir 1% gel for HIV prevention; the trial has completed.